With a smartly-assembled supporting cast around a stoic star, the New York Knicks assembled the right pieces of the puzzle en ...

Learn how to use ChatGPT Codex as an AI teammate to automate workflows, manage files, and streamline your daily tasks without ...

Do you know how to read sports betting odds? They are the driving force behind wagering on sports. In this comprehensive guide, we break down what sports betting odds are, all the different types of ...

Box, a Silicon Valley software maker, expects to have more employees, not fewer, as it hires A.I. architects, A.I. solutions managers and other new A.I.-related positions. By Kalley Huang Reporting ...

For quite some time, Hollywood has moaned about the lost YouTube generation at the box office: How do we get the Gen Z set in? Sure, they’ll show up for a Marvel movie, but today’s 18-25 demo aren’t ...

Mr. Bannon is the chief librarian of the New York Public Library, where he is also the director of branch libraries and education. See more of our coverage in your search results.Encuentra más de ...

Box Elder County Attorney Stephen R. Hadfield determined that no referendum application “is legally referable to voters” — but also makes way for a potential lawsuit.

The first time I saw Obsession, I had two immediate thoughts: 1) This movie rules, and 2) This movie is so disturbing that most people I know will hate it. Turns out, I was right about that first ...

Curry Barker, a 26-year-old YouTuber-turned-filmmaker, made his horror film “Obsession” in just 20 days on a mere $750,000 budget. Subscribe to read this story ad-free Get unlimited access to ad-free ...

Google just announced Gemini Omni, a new AI model that it claims can “create anything from any input,” at its annual I/O developer conference on Tuesday. The company said the model is starting off ...

This is an edition of The Wonder Reader, a newsletter in which our editors recommend a set of stories to spark your curiosity and fill you with delight. Sign up here to get it every Saturday morning.

While Create’s autoimmune pipeline is entirely preclinical, it has dosed more than 50 patients in trials of its cancer candidates. (iStock / Getty Images Plus) As the wave of in vivo CAR-T hype crests ...